Tirzepatide produced an average body-weight reduction of 20.2%, while semaglutide produced an average reduction of 13.7%
Metabolic & GLP-1 Research GLP-1 research peptides and multi-receptor agonist compounds studied for glucose regulation, insulin signalling, and energy metabolism in laboratory models
Our team will monitor your progress closely, helping you track any side effects, changes in appetite, blood sugar levels, and overall well-being
Additionally, uncontrolled hyperglycemia itself causes dry mouth through osmotic diuresis, though semaglutide's glucose-lowering effects should theoretically improve rather than worsen this symptom in patients with diabetes
Most available reports employ a bulky phase transfer agents (e.g